PLoS medicine, Vol. 5, No. 4. (1 April 2008)
JAMA, Vol. 299, No. 2. (9 January 2008), pp. 185-193.
Molecular Psychiatry, Vol. aop, No. current.
Br J Psychiatry, Vol. 192 (February 2008), pp. 135-143.
by M
Tohen, CL
Bowden, AB
Smulevich, R
Bergstrom, T
Quinlan, O
Osuntokun, WV
Wang, HS
Oliff, F
Martenyi, LA
Kryzhanovskaya, W
Greil
Nat Med (2 September 2007)
by Sandeep T T
Patil, Lu
Zhang, Ferenc
Martenyi, Stephen L L
Lowe, Kimberley A A
Jackson, Boris V V
Andreev, Alla S S
Avedisova, Leonid M M
Bardenstein, Issak Y Y
Gurovich, Margarita A A
Morozova, Sergey N N
Mosolov, Nikolai G G
Neznanov, Alexander M M
Reznik, Anatoly B B
Smulevich, Vladimir A A
Tochilov, Bryan G G
Johnson, James A A
Monn, Darryle D D
Schoepp
Am J Psychiatry, Vol. 164, No. 9. (September 2007), pp. 1411-1417.
Sao Paulo Med J, Vol. 124, No. 5. (7 September 2006), pp. 291-297.
Drug Saf, Vol. 30, No. 7. (2007), pp. 569-579.
Am J Psychiatry, Vol. 164, No. 8. (August 2007), pp. 1214-1220.
by DJ
Newport, MR
Calamaras, CL
Devane, J
Donovan, AJ
Beach, S
Winn, BT
Knight, BB
Gibson, AC
Viguera, MJ
Owens, CB
Nemeroff, ZN
Stowe
Trends Pharmacol Sci, Vol. 28, No. 4. (April 2007), pp. 166-172.
Arch Gen Psychiatry, Vol. 64, No. 6. (June 2007), pp. 633-647.
by RS
Keefe, RM
Bilder, SM
Davis, PD
Harvey, BW
Palmer, JM
Gold, HY
Meltzer, MF
Green, G
Capuano, TS
Stroup, JP
McEvoy, MS
Swartz, RA
Rosenheck, DO
Perkins, CE
Davis, JK
Hsiao, JA
Lieberman
J. Neurosci., Vol. 27, No. 22. (30 May 2007), pp. 5895-5902.
Am J Psychiatry, Vol. 164, No. 6. (1 June 2007), pp. 870-876.
Psychopharmacol Bull, Vol. 40, No. 1. (2007), pp. 77-97.
BMJ, Vol. 334, No. 7595. (31 March 2007), pp. 686-692.
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, No. 1. (February 2007), pp. 17-29.
Proc Natl Acad Sci U S A, Vol. 104, No. 9. (27 February 2007), pp. 3456-3459.
Cell Metab, Vol. 1, No. 1. (January 2005), pp. 15-25.
Drug Safety, Vol. 30, No. 3. (2007), pp. 247-264.
Drug Safety, Vol. 30, No. 1. (2007), pp. 47-57.
by
Haas, J
Steven,
Hill,
Richard,
Krum,
Henry,
Liew,
Danny,
Tonkin,
Andrew,
Demos,
Lisa,
Stephan,
Karen,
Mcneil,
John
Drug Safety, Vol. 30, No. 2. (2007), pp. 171-184.
CNS Drugs, Vol. 20, No. 3. (2006), pp. 187-198.
Prog Neuropsychopharmacol Biol Psychiatry, Vol. 30, No. 4. (June 2006), pp. 541-548.
Drug Saf, Vol. 29, No. 4. (2006), pp. 303-319.
Drug Saf, Vol. 29, No. 2. (2006), pp. 95-118.
Psychopharmacology (Berl), Vol. 185, No. 3. (April 2006), pp. 265-273.
Am J Psychiatry, Vol. 163, No. 12. (December 2006), pp. 2064-2070.
Prog Neuropsychopharmacol Biol Psychiatry, Vol. 27, No. 7. (October 2003), pp. 1101-1111.
Curr Drug Targets, Vol. 7, No. 9. (September 2006), pp. 1225-1229.
J Clin Psychopharmacol, Vol. 26, No. 6. (December 2006), pp. 600-609.
N Engl J Med, Vol. 353, No. 12. (22 September 2005), pp. 1209-1223.
by JA
Lieberman, TS
Stroup, JP
McEvoy, MS
Swartz, RA
Rosenheck, DO
Perkins, RS
Keefe, SM
Davis, CE
Davis, BD
Lebowitz, J
Severe, JK
Hsiao,
Br J Psychiatry, Vol. 190, No. 2. (1 February 2007), pp. 129-134.
Clin Neuropharmacol, Vol. 29, No. 5. (t 2006), pp. 265-268.
N Engl J Med, Vol. 355, No. 8. (24 August 2006), pp. 818-829.
Mayo Clin Proc, Vol. 80, No. 8. (August 2005), pp. 1050-1057.
Am J Psychiatry, Vol. 163, No. 5. (May 2006), pp. 833-838.
by MK
Nickel, M
Muehlbacher, C
Nickel, C
Kettler, F
Pedrosa Gil, E
Bachler, W
Buschmann, N
Rother, R
Fartacek, C
Egger, J
Anvar, WK
Rother, TH
Loew, P
Kaplan
Drug Saf, Vol. 29, No. 6. (2006), pp. 491-508.
Molecular Psychiatry, Vol. aop, No. current.
Ann Pharmacother, Vol. 40, No. 11. (November 2006), pp. 1966-1973.